22
Participants
Start Date
February 28, 2015
Primary Completion Date
March 31, 2018
Study Completion Date
February 29, 2020
Placebo
Patients will be treated by placebo
Fluticasone propionate
Patients will receive fluticasone nasal spray
Fluticasone/Azelastine nasal spray
Patients will receive Dymista nasal spray
Nasal Allergen Challenge
All subjects will receive a nasal challenge with allergen to mimick an allergic response and allow the investigation of the different drug effects on that response. Allergen extracts will be used as sprays into the nasal cavity. The extracts are approved by FDA for skin testing or desensitization therapy and an IND was obtained to allow intranasal administration
The University of Chicago Medicine, Chicago
University of Chicago
OTHER